GENEVA, Aug. 21 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH filed a patent application (EP2026/053537) for “COMPOSITIONS AND DOSE REGIMEN OF NERANDOMILAST IN COMBINATION WITH STRONG CYP 3A-INHIBITORS”. With publication no. WO/2026/171720, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/519
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....